He Benny Chang1, Sara Munroe2, Katarina Gray3, Giovanna Porta2, Antoine Douaihy4, Anna Marsland3, David Brent4, Nadine M Melhem5. 1. University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA. 2. University of Pittsburgh Medical Center, USA. 3. Department of Psychology, University of Pittsburgh, USA. 4. Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. 5. Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. Electronic address: melhemnm@upmc.edu.
Abstract
BACKGROUND: Alcohol and substance use disorders are important predictors for suicidal behavior. However, the role of individual substances as proximal risk factors for suicidal behavior and the mechanisms through which substance use affect risk are not entirely clear. We examine whether the frequency of substance use and whether biological markers in the HPA axis and inflammatory pathways are associated with clinical risk factors of suicidal behavior of aggression, impulsivity, hopelessness, and poor sleep. METHODS: The sample consisted of psychiatric inpatients, aged 15-30 years, admitted for suicide attempt (n = 38), suicidal ideation (n = 40); and healthy controls (n = 37). We measured hair cortisol concentrations, glucocorticoid receptor (GR) sensitivity, stimulated production of interleukin- or IL-6, C-reactive protein, and mRNA expression of GR, SKA2, FKBP5, TNF-α, and IL-1β. RESULTS: Smoking was associated with increased aggression [β = 2.9, 95% CI (-0.03, 6), p = 0.05], impulsivity [β = 3.1, 95% CI (1.6, 4.6), p < 0.001], and poor sleep [β = 0.5, 95% CI (0.03, 0.95), p = 0.04] even after controlling for demographics and group. Similarly, TNF-α mRNA was associated with impulsivity [β = 0.07, 95% CI (0.01, 0.1), p = 0.02] and hopelessness [β = 0.03, 95% CI (0.004, 0.05), p = 0.03]. Smoking tobacco (r = 0.32, p < 0.001) was positively associated with TNF-α mRNA. LIMITATIONS: Study limitations include the cross-sectional design, retrospective assessment, and relatively small sample size. CONCLUSIONS: Future longitudinal studies are needed to test whether inflammatory markers mediate the relationships between smoking, clinical risk factors, and suicidal behavior; and to examine whether smoking cessation could reduce the risk for suicidal behavior in at-risk patients.
BACKGROUND:Alcohol and substance use disorders are important predictors for suicidal behavior. However, the role of individual substances as proximal risk factors for suicidal behavior and the mechanisms through which substance use affect risk are not entirely clear. We examine whether the frequency of substance use and whether biological markers in the HPA axis and inflammatory pathways are associated with clinical risk factors of suicidal behavior of aggression, impulsivity, hopelessness, and poor sleep. METHODS: The sample consisted of psychiatric inpatients, aged 15-30 years, admitted for suicide attempt (n = 38), suicidal ideation (n = 40); and healthy controls (n = 37). We measured hair cortisol concentrations, glucocorticoid receptor (GR) sensitivity, stimulated production of interleukin- or IL-6, C-reactive protein, and mRNA expression of GR, SKA2, FKBP5, TNF-α, and IL-1β. RESULTS: Smoking was associated with increased aggression [β = 2.9, 95% CI (-0.03, 6), p = 0.05], impulsivity [β = 3.1, 95% CI (1.6, 4.6), p < 0.001], and poor sleep [β = 0.5, 95% CI (0.03, 0.95), p = 0.04] even after controlling for demographics and group. Similarly, TNF-α mRNA was associated with impulsivity [β = 0.07, 95% CI (0.01, 0.1), p = 0.02] and hopelessness [β = 0.03, 95% CI (0.004, 0.05), p = 0.03]. Smoking tobacco (r = 0.32, p < 0.001) was positively associated with TNF-α mRNA. LIMITATIONS: Study limitations include the cross-sectional design, retrospective assessment, and relatively small sample size. CONCLUSIONS: Future longitudinal studies are needed to test whether inflammatory markers mediate the relationships between smoking, clinical risk factors, and suicidal behavior; and to examine whether smoking cessation could reduce the risk for suicidal behavior in at-risk patients.
Authors: Ghanshyam N Pandey; Hooriyah S Rizavi; Xinguo Ren; Jawed Fareed; Debra A Hoppensteadt; Rosalinda C Roberts; Robert R Conley; Yogesh Dwivedi Journal: J Psychiatr Res Date: 2011-09-08 Impact factor: 4.791
Authors: Nadine M Melhem; David A Brent; Melissa Ziegler; Satish Iyengar; David Kolko; Maria Oquendo; Boris Birmaher; Ainsley Burke; Jamie Zelazny; Barbara Stanley; J John Mann Journal: Am J Psychiatry Date: 2007-09 Impact factor: 18.112
Authors: Donald M Dougherty; Charles W Mathias; Michael A Dawes; R Michael Furr; Nora E Charles; Anthony Liguori; Erin E Shannon; Ashley Acheson Journal: Psychopharmacology (Berl) Date: 2012-11-09 Impact factor: 4.530
Authors: Mallory E Stephenson; Sara Larsson Lönn; Jessica E Salvatore; Jan Sundquist; Kenneth S Kendler; Kristina Sundquist; Alexis C Edwards Journal: Clin Psychol Sci Date: 2021-06-23
Authors: Yongqi Zhong; Steven Pham; Giovanna Porta; Antoine Douaihy; Anna Marsland; David Brent; Nadine M Melhem Journal: Psychol Med Date: 2020-10-19 Impact factor: 7.723
Authors: Alicia Edith Hermosillo-de-la-Torre; Stephania Montserrat Arteaga-de-Luna; Denise Liliana Acevedo-Rojas; Angélica Juárez-Loya; José Alberto Jiménez-Tapia; Francisco Javier Pedroza-Cabrera; Catalina González-Forteza; Manuel Cano; Fernando A Wagner Journal: Int J Environ Res Public Health Date: 2021-05-07 Impact factor: 3.390